{"symbol":"BMY","fiscalQuarter":"Q3-2010","reportDate":"2010-10-26","reportTime":"BMO","status":"reported","company":{"name":"Bristol-Myers Squibb Company","sector":"Health Care","industry":"Pharmaceuticals"},"tier":"free","webUrl":"https://earningsnxt.ai/ticker/BMY/earnings/Q3-2010","postBrief":{"headline":"Bristol-Myers Squibb Beats on EPS, Stock Down 1.1%","keyNumbers":[{"metric":"EPS","actual":"$0.59","expected":"N/A","surprise":"+11.11%"},{"metric":"Revenue","actual":"N/A","expected":"N/A","surprise":"N/A"}],"managementCommentary":{"tone":"Unknown","keyQuotes":[],"summary":"No transcript is on record for this earnings call, so the analysis is based solely on numerical results."},"guidanceChanges":{"summary":"No forward guidance data is available for this quarter.","changes":[]},"whatItMeans":"Bristol-Myers Squibb reported a better-than-expected EPS, which indicates some positive performance in their operations. However, the stock fell by 1.1%, suggesting that investors may have been looking for more comprehensive revenue details or guidance. The lack of additional information from the earnings call may have contributed to the stock's decline.","metaDescription":"Bristol-Myers Squibb (BMY) Q3 2010 earnings: EPS beat, revenue not disclosed. Stock down 1.1%. Full breakdown."}}